CD4 and COVID-19: In addition, IL‐6 cytokines were elevated in COVID‐19 patients with myocardial injury, justifying the emergence of severity of inflammation, also immune‐related markers, like CD3, CD4, CD8 molecules counts and lymphocyte counts were all reduced, more significant in patients with myocardial injury.